Virbac S.A. is a leading pharmaceutical company dedicated exclusively to animal health. Established in 1968 by French veterinarian Pierre-Richard Dick, the company has built a global presence, serving... Virbac S.A. is a leading pharmaceutical company dedicated exclusively to animal health. Established in 1968 by French veterinarian Pierre-Richard Dick, the company has built a global presence, serving veterinarians, farmers, and pet owners in over 100 countries. Virbac develops, manufactures, and markets a comprehensive portfolio of products, including vaccines, antibiotics, parasiticides, dental care items, nutritional supplements, diagnostics, anti-inflammatory, and dermatological treatments. These solutions are designed to address a wide range of health needs for both companion animals and livestock. Notably, Virbac invests heavily in research and development, consistently introducing innovative therapies—such as recent antimicrobial-free treatments for canine conditions and licensed therapeutic antibodies for canine diseases—to improve animal well-being. Headquartered in Carros Cedex, France, Virbac operates manufacturing and R&D centers worldwide and stands as the world’s sixth largest veterinary biopharma group, recognized for its independent ethos and commitment to advancing global animal health.
Pending data availability
Energy Management Data missing for Virbac
We haven’t collected Energy Management data for Virbac yet, or the company
hasn’t made it publicly available.